Subscribe to Newsletter

Drug Discovery

Discovery & Development Clinical Trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.
Discovery & Development Drug Discovery

COVID-19: Llamas to the Rescue

| Maryam Mahdi

Llama antibodies may be crucial in the fight against COVID-19.
Discovery & Development Drug Discovery

Intelligent Repurposing

| Maryam Mahdi

An AI platform seeks out drugs that can be repurposed to treat COVID-19.
Discovery & Development Drug Discovery

Preventing Preterm Problems

| Maryam Mahdi

Researchers have identified four drugs capable of preventing preterm labor and birth.
Discovery & Development Drug Discovery

Branching Out

| Maryam Mahdi

How can we reduce AI's energy consumption for improved drug discovery?
Discovery & Development Drug Discovery

Preventing the Viral Trigger Pull

| Michael Schubert

A new vaccine protects against type 1 diabetes in animal models.
Discovery & Development Drug Discovery

Trial Ready

The University of Oxford receives its first batch of AZD1222, a coronavirus vaccine candidate.
Discovery & Development Drug Discovery

ADCs on the Rise

How will the ADC sector fair in 2020 and beyond?
Business & Regulation Business Practice

Access Not Denied

| Stephanie Vine

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.
Discovery & Development Drug Discovery

Calming the Cytokine Storm

| Maryam Mahdi

How can salivary proteins derived from ticks help treat COVID-19?
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

February Issue of The Medicine Maker